Canada needs national approach to protect against drug shortages

Canada needs a national approach to managing its supply of pharmaceutical drugs, starting with a mandatory reporting system for drug shortages, argues an editorial in CMAJ (Canadian Medical Association Journal) and CPJ (Canadian Pharmacists Journal).

Shortages of drugs, particularly those used in chemotherapy, as well as antibiotics, antiepileptics and anesthetics, have become increasingly common, unpredictable and widespread in Canada. These shortages result in poorer health for Canadians, with consequences such as worsening of medical conditions, negative reactions to substitute drugs, cancellation of surgeries and procedures, and increased costs to patients and the .

"It is ridiculous and intolerable that a wealthy, developed nation like Canada cannot reliably provide medicines to its people," write Dr. Matthew Stanbrook, Deputy Editor, , and Rosemary Killeen, Editor-in-Chief, CPJ.

"Although the causes of drug shortages are myriad and complex, Canada's lack of preparedness for and ability to cope with this problem seem more readily apparent," the authors write. "One salient feature is the absence of integrated, coordinated national leadership on drug policy in Canada."

Europe and the United States require pharmaceutical companies to inform governments in advance of possible . Canada, however, is relying on industry to establish a voluntary reporting system rather than establishing a mandatory reporting system.

"A mandatory for impending shortages should be created and maintained, so that health care stakeholders at all levels have adequate and timely information with which to make decisions," state the authors.

With national leadership to manage the issue, Canada could take other steps to minimize the effect of shortages, including:

  • expanding the national pharmaceutical drug stockpile
  • mandating that there must be at least two or more suppliers for essential drugs
  • establishing a system to share supplies across the country and to restock quickly from international suppliers if there is a shortage.
"The people of Canada deserve greater responsiveness and action from their elected officials to safeguard the supply of some of the most critical components of health care delivery," the authors conclude.

More information: www.cmaj.ca/lookup/doi/10.1503/cmaj.121196 and www.cpjournal.ca/doi/pdf/10.3821/145.5.cpj380

add to favorites email to friend print save as pdf

Related Stories

Quality health care delivery key election issue, says CMAJ

Apr 06, 2011

Delivering quality health care rather than health care sustainability is a key issue for Canada's federal election, and Canadians need a vision from federal leaders to radically transform our health care system, states an ...

No double standards for natural health products

Nov 14, 2011

Natural health products and medicinal foods should be subject to the same regulations as pharmaceutical drugs to ensure safety and efficacy, states an editorial in CMAJ (Canadian Medical Association Journal).

Recommended for you

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.